Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia

American Journal of Hypertension

Volumn 23, Issue 3, 2010, Pages 321-326

  Orlov, Sergei N ^a,b   Gossard, Francis ^a   Pausova, Zdenka ^c   Akimova, Olga A ^a,b   Tremblay, Johanne ^a   Grim, Clarence E ^d   Kotchen, Jane M ^d   Kotchen, Theodore A ^d   Gaudet, Daniel ^e   Cowley, Allen W ^d   Hamet, Pavel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e Lipid Clinic   (Canada)

Author keywords

African Americans; Blood pressure; Hypertension; Na+,K+,Cl co transport; Plasma lipids; Renal complications; Salt retention

Indexed keywords

BUMETANIDE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OUABAIN; RUBIDIUM 86; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANIMALS; BODY MASS INDEX; DYSLIPIDEMIAS; ERYTHROCYTES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; RATS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; YOUNG ADULT;

EID: 76749116178     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.249     Document Type: Article

References (39)

1. Postnov YU, Orlov S, Gulak P, Shevchenko A. Altered permeability of the erythrocyte membrane for sodium and potassium ions in spontaneously hypertensive rats. Pflugers Arch 1976; 365:257-263.
2. Friedman SM, Nakashima M, McIndoe RA, Friedman CL. Increased erythrocyte permeability to Li and Na in the spontaneously hypertensive rat. Experientia 1976; 32:476-478.
3. Orlov SN, Adragna NC, Adarichev VA, Hamet P. Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension. Am J Physiol 1999; 276:C511-C536.
4. Orlov SN. Hypertension. In Bernhardt I, Ellory JC (eds). Red Cell Membrane Transport in Health and Disease. Springer: Berlin, 2003, pp 587-602.
5. Garay R P, Alda O. What can we learn from erythrocyte Na-K-Cl cotransporter NKCC1 in human hypertension? Pathophysiology 2007; 14:167-170.
6. Gamba G. Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiol Rev 2005; 85:423-493. (Pubitemid 40404634)
7. Watson KE. Cardiovascular risk reduction among African Americans: a call to action. J Natl Med Assoc 2008; 100:18-26.
8. Krakoff LR. Diuretics for hypertension. Circulation 2005; 112:e127-e129.
9. Pratt JH. Central role for ENaC in development of hypertension. J Am Soc Nephrol 2005; 16:3154-3159.
10. Dill DB, Yousef MK, Goldman A, Hillyard SD, Davis T P. Volume and composition of hand sweat of White and Black men and women in desert walks. Am J Phys Anthropol 1983; 61:67-73.
11. Singh J, Gross M, Sage B, Davis HT, Maibach HI. Effect of saline iontophoresis on skin barrier function and cutaneous irritation in four ethnic groups. Food Chem Toxicol 2000; 38:717-726.
12. Orlov SN. Decreased Na+,K+,2Cl-cotransport and salt retention in Blacks: a provocative hypothesis. J Hypertens 2005; 23:1929-1930.
13. Canessa ML. The Na-K-Cl cotransport in essential hypertension: cellular functions and genetic environment interactions. Int J Cardiol 1989; 25(Suppl 1):S37-S45.
14. Garay R P, Nazaret C, Dagher G, Bertrand E, Meyer P. A genetic approach to the geography of hypertension: examination of Na+-K+ cotransport in Ivory Coast Africans. Clin Exp Hypertens 1981; 3:861-870.
15. Orlov SN, Pausova Z, Gossard F, Gaudet D, Tremblay J, Kotchen T, Cowley A, Larochelle P, Hamet P. Sibling resemblance of erythrocyte ion transporters in French-Canadian sibling-pairs affected with essential hypertension. J Hypertens 1999; 17:1859-1865.
16. Tuck ML, Gross C, Maxwell MH, Brickman AS, Krasnoshtein G, Mayes D. Erythrocyte Na+,K+ cotransport and Na+,K+ pump in black and caucasian hypertensive patients. Hypertension 1984; 6:536-544.
17. Canessa M, Spalvins A, Adragna N, Falkner B. Red cell sodium countertransport and cotransport in normotensive and hypertensive blacks. Hypertension 1984; 6:344-351.
18. Zicha J, Kunes J, Devynck MA. Abnormalities of membrane function and lipid metabolism in hypertension: a review. Am J Hypertens 1999; 12:315-331.
19. Weder AB, Torretti BA, Julius S. Racial differences in erythrocyte cation transport. Hypertension 1984; 6:115-123.
20. Pausova Z, Jomphe M, Houde L, Vezina H, Orlov SN, Gossard F, Gaudet D, Tremblay J, Kotchen TA, Cowley AW, Bouchard G, Hamet P. A genealogical study of essential hypertension with and without obesity in French Canadians. Obes Res 2002; 10:463-470.
21. Kotchen TA, Piering AW, Cowley AW, Grim CE, Gaudet D, Hamet P, Kaldunski ML, Kotchen JM, Roman RJ. Glomerular hyperfiltration in hypertensive African Americans. Hypertension 2000; 35:822-826.
22. Akimova OA, Grygorczyk A, Bundey RA, Bourcier N, Gekle M, Insel PA, Orlov SN. Transient activation and delayed inhibition of Na+,K+,Cl-cotransport in ATP-treated C11-MDCK cells involve distinct P2Y receptor subtypes and signaling mechanisms. J Biol Chem 2006; 281:31317-31325.
23. Orlov SN, Pokudin NI, Kotelevtsev YV, Gulak PV. Volume-dependent regulation of ion transport and membrane phosphorylation in human and rat erythrocytes. J Membr Biol 1989; 107:105-117.
24. Solban N, Jia H P, Richard S, Tremblay S, Devlin AM, Peng J, Gossard F, Guo DF, Morel G, Hamet P, Lewanczuk R, Tremblay J. HCaRG, a novel calcium-regulated gene coding for a nuclear protein, is potentially involved in the regulation of cell proliferation. J Biol Chem 2000; 275:32234-32243.
25. Flagella M, Clarke LL, Miller ML, Erway LC, Giannella RA, Andringa A, Gawenis LR, Kramer J, Duffy JJ, Doetschman T, Lorenz JN, Yamoah EN, Cardell EL, Shull GE. Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem 1999; 274:26946-26955.
26. Koltsova SV, Kotelevtsev SV, Tremblay J, Hamet P, Orlov SN. Excitation-contraction coupling in resistance mesenteric arteries: evidence for NKCC1-mediated pathway. Biochem Biophys Res Commun 2009; 379:1080-1083.
27. Wall SM, Knepper MA, Hassell KA, Fischer M P, Shodeinde A, Shin W, Pham TD, Meyer JW, Lorenz JN, Beierwaltes WH, Dietz JR, Shull GE, Kim YH. Hypotension in NKCC1 null mice: role of the kidneys. Am J Physiol Renal Physiol 2006; 290: F409-F416.
28. Kotchen TA, Kotchen JM, Grim CE, Krishnaswami S, Kidambi S. Aldosterone and alterations of hypertension-related vascular function in African Americans. Am J Hypertens 2009; 22:319-324.
29. Castrop H, Lorenz JN, Hansen PB, Friis U, Mizel D, Oppermann M, Jensen BL, Briggs J, Skøtt O, Schnermann J. Contribution of the basolateral isoform of the Na-K-2Cl-cotransporter (NKCC1/BSC2) to renin secretion. Am J Physiol Renal Physiol 2005; 289:F1185-F1192.
30. Chun TY, Bankir L, Eckert GJ, Bichet DG, Saha C, Zaidi SA, Wagner MA, Pratt JH. Ethnic differences in renal responses to furosemide. Hypertension 2008; 52: 241-248.
31. Kim SM, Eisner C, Faulhaber-Walter R, Mizel D, Wall SM, Briggs J P, Schnermann J. Salt sensitivity of blood pressure in NKCC1-deficient mice. Am J Physiol Renal Physiol 2008; 295:F1230-F1238.
32. Chipperfield AR, Harper AA. Chloride in smooth muscle. Prog Biophys Mol Biol 2000; 74:175-221.
33. Akar F, Jiang G, Paul RJ, O'Neill WC. Contractile regulation of the Na(+)-K(+)-2Cl(-) cotransporter in vascular smooth muscle. Am J Physiol Cell Physiol 2001; 281:C579-C584.
34. Orlov SN. NKCC1 as a regulator of vascular tone and a novel target for antihypertensive therapeutics. Am J Physiol Heart Circ Physiol 2007; 292: H2035-H2036.
35. Wang X, Breaks J, Loutzenhiser K, Loutzenhiser R. Effects of inhibition of the Na+/K+/2Cl-cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole. Am J Physiol Renal Physiol 2007; 292:F999-F1006.
36. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999; 79:387-423.
37. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1153-R1167.
38. Boone CA. End-stage renal disease in African-Americans. Nephrol Nurs J 2000; 27:597-600.
39. Barri YM. Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep 2008; 10:39-45.